Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis

Background: Severe acute respiratory syndrome coronavirus 2 (SARS−CoV−2) has been declared a global pandemic by the World Health Organisation and urgent treatment and prevention strategies are needed. Many clinical trials have been initiated with existing medications, but assessments of the expected...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:medRxiv
Main Authors: Rajoli, Rajith KR, Pertinez, Henry, Arshad, Usman, Box, Helen, Tatham, Lee, Curley, Paul, Neary, Megan, Sharp, Joanne, Liptrott, Neill J, Valentijn, Anthony, David, Christopher, Rannard, Steve P, Aljayyoussi, Ghaith, Pennington, Shaun H, Hill, Andrew, Boffito, Marta, Ward, Stephen A, Khoo, Saye H, Bray, Patrick G, O'Neill, Paul M., Hong, W. Dave, Biagini, Giancarlo, Owen, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274229/
https://ncbi.nlm.nih.gov/pubmed/32511548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.01.20087130
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados